$HIPO Cashflow Statement | Understand Stock

$HIPO

$37.71 -$0.59 (1.54%) Close

$HIPO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock–based compensation expense
Change in fair value of preferred stock warrant liabilities
Other changes in fair value
Change in fair value of contingent consideration liability
Impairment charges
Change in fair value of derivative liability on notes
Amortization of debt discount
Gain on extinguishment of debt
Non-cash interest expense
Non-cash service expense
Fair value adjustments
Impairment and restructuring charges
Gain on sale of business
Other non-cash items

Changes in assets and liabilities:
Accounts receivable, net
Reinsurance recoverables
Ceding commissions receivable
Prepaid reinsurance premiums
Other assets
Provision for commission
Accrued expenses and other liabilities
Losses and loss adjustment expense reserves
Unearned premiums
Reinsurance premiums payable
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Capitalized internal use software costs
Purchase of intangible assets
Disposal Group, Including Discontinued Operation, Assets
Purchases of property and equipment
Purchases of fixed maturities
Maturities of fixed maturities
Sales of fixed maturities
Cash paid for acquisitions, net of cash acquired
Purchases of short-term investments
Maturities of short-term investments
Sales of short-term investments
Proceeds from sale of business, net
Other
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from preferred shares, net of issuance costs
Proceeds from surplus note, net
Taxes paid related to net share settlement of equity awards
Proceeds from the exercise of preferred stock warrants
Proceeds from reverse recapitalization, net of redemptions, secondaries and costs
Proceeds from exercise of options
Proceeds from issuance of common stock
Share repurchases under program
Payments of contingent consideration
Proceeds from promissory notes, net of issuance costs
Other
Acquisitions of noncontrolling interests
Distributions to noncontrolling interests and other
Net cash used in financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at the beginning of the period
Cash, cash equivalents, and restricted cash at the end of the period
Conversion of preferred stock for common stock
Conversion of convertible notes for common stock
Acquisition of public and private placement warrants
Convertible promissory notes issued for services
Equity issued for acquisitions

Comments